ID   Y1-8BrcAMPr-1
AC   CVCL_5G24
SY   8BrcAMPr-1
DR   Wikidata; Q54995166
RX   PubMed=200506;
RX   PubMed=215599;
CC   Selected for resistance to: ChEBI; CHEBI:64211; 8-bromo-3',5'-cyclic AMP (8-bromoadenosine 3',5'-cyclic monophosphate; 8-Br-cAMP).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: LAF1.
DI   NCIt; C22992; Mouse adrenal cortical carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_W154 ! Y1-BS1
SX   Male
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 6
//
RX   PubMed=200506; DOI=10.1016/0303-7207(77)90025-9;
RA   Schimmer B.P., Tsao J., Knapp M.;
RT   "Isolation of mutant adrenocortical tumor cells resistant to cyclic
RT   nucleotides.";
RL   Mol. Cell. Endocrinol. 8:135-145(1977).
//
RX   PubMed=215599; DOI=10.1002/jcp.1040970320;
RA   Gutmann N.S., Rae P.A., Schimmer B.P.;
RT   "Altered cyclic AMP-dependent protein kinase activity in a mutant
RT   adrenocortical tumor cell line.";
RL   J. Cell. Physiol. 97:451-460(1978).
//